Alnylam Pharmaceuticals
ALNY
#690
Rank
$37.92 B
Marketcap
$284.02
Share price
-1.31%
Change (1 day)
-8.02%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend yield history for this company